People's Hospital of Liaoning Province

Shenyang 110067

2 studies enrolling now · 5 studies all time

What they study most

Atrial Fibrillation, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Heart Failure, Hypertension, Myocardial Infarction, Stroke, Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart — Recruiting now
• A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) — Running, not enrolling
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• GLORIA-AF Registry Program - Second and Third Phases — Completed